Oncolytic virotherapy with modified adenoviruses and novel therapeutic targets

Author： Halldén Gunnel   Portella Giuseppe  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.16, Iss.10, 2012-10, pp. : 945-958

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic Virotherapy for Breast Cancer Treatment

By  

Current Gene Therapy, Vol. 18, Iss. 4, 2018-08 ,pp. : 192-205

Bentham Science Publishers

Access to resources Recommend Favorite

Selectively Replicating Adenoviruses for Oncolytic Therapy

By  

Current Cancer Drug Targets, Vol. 1, Iss. 2, 2001-08 ,pp. : 85-107

Bentham Science Publishers

Access to resources Recommend Favorite

Novel therapeutic targets in chordoma

By Bydon Mohamad   Papadimitriou Kyriakos   Witham Timothy   Wolinsky Jean-Paul   Bydon Ali   Sciubba Daniel   Gokaslan Ziya  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 11, 2012-11 ,pp. : 1139-1143

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutic targets in osteoporosis

By Tobias JH   Flanagan AM   Scutt AM  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 1, 2002-02 ,pp. : 41-56

Informa Healthcare

Access to resources Recommend Favorite

Novel strategies in tailoring human adenoviruses into therapeutic cancer gene therapy vectors

By Lindholm Leif   Henning Petra   Magnusson Maria K  

Future Virology, Vol. 3, Iss. 1, 2008-01 ,pp. : 45-59

Future Medicine

Access to resources Recommend Favorite